|Articles|May 26, 2017

WHO Confirms Active Zika Transmission in India

Author(s)Sarah Anwar

After 3 individuals test positive for the mosquito-borne virus in Gujarat, WHO confirms that the Zika virus is currently circulating in the country.

The World Health Organization (WHO) just released an official statement confirming active Zika virus transmission in India.

According to the release, laboratory testing using reverse transcription-polymerase chain reaction (RT-PCR) confirmed Zika virus infection in 3 patients from the Bapunagar area, Ahmedabad District, Gujarat.

The first case was identified in February 2016. The male, 64 years of age, presented with febrile illness, which he had been experiencing for 8 days. He tested negative for Dengue virus infection, and was then tested for Zika virus at B. J. Medical College in Ahmedabad (BJMC), which came back positive.

In November of the same year, a female, 34 years of age, gave birth to an infant who was found to be “clinically well.” However, the new mother came down with a “low grade fever” after delivery. She had no history of travel in the 3 months prior to delivery. Lab testing confirmed she was not infected with Dengue, but that she has Zika infection, which was confirmed by “RT-PCR testing and sequencing” at the National Institute of Virology in Pune.

The third case was identified in January of 2017. The individual, a 22-year-old female, was 37 weeks pregnant when she tested positive for the mosquito-borne virus.

According to the WHO risk assessment, this report “describes the first cases of Zika virus infections and provides evidence on the circulation of the virus in India.” Although WHO claims that Zika transmission in the country is currently at low levels, it is believed that “new cases may occur in the future,” as “risk of further spread of Zika virus to areas where the competent vectors, the Aedes mosquitoes, are present is significant.”

Therefore, WHO urges health officials to increase surveillance of complications associated with the virus, as well as increase efforts to “better characterize the intensity of the viral circulation and geographical spread” of Zika. In addition, WHO recommends performing vector-control efforts. There are currently no recommendations to limit travel to India.


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.